1. Recombinant human erythropoietin in patients on hemodialysis: United States;Eschbach, J.W.,1991
2. Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis;Sinai-Trieman, L.; Salusky, I.B.; Fine, R.N.;YPediatr,1989
3. Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis;Montini, G.; Zacchello, G.; Baraldi, E.;J Pediatr,1990
4. Anemia of chronic renal failure: treatment with erythropoietin;Navarro, M.; Alonso, A.; Avilla, J.M.; Espinosa, L.;Child Nephrol Urol,1991
5. Short term correction of anaemia with recombinant human erythropoietin and reduction of cardiac output in end stage renal failure;Morris, K.P.; Skinner, JR, Hunter; S, Coulthard; M.G.;Arch Dis Child,1993